Joint Formulary & PAD

Paritaprevir/ritonavir/ombitasvir - Hepatitis C

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :

No records returned.

Associated Icons :
NHSE
R
SPC
Restrictions / Comments :
Important

requires approval from HCV national team for use

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Paritaprevir/ritonavir/ombitasvir
Indication :
Hepatitis C
Group Name :
Keywords :
antiviral
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Paritaprevir/ritonavir/ombitasvir is used to treat.

  • No records returned.

Committee Recommendations (0)

  • No records returned.